Kashif Rashid's most recent trade in Nevro Corp was a trade of 1,136 Common Stock done . Disclosure was reported to the exchange on March 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 1,136 | 141,073 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.78 per share. | 20 Mar 2025 | 611 | 140,462 (0%) | 0% | 5.8 | 3,532 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 07 Mar 2025 | 15,136 | 139,937 (0%) | 0% | 5.8 | 87,335 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 07 Mar 2025 | 1,758 | 155,073 (0%) | 0% | 5.8 | 10,144 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 28 Feb 2025 | 944 | 156,831 (0%) | 0% | 5.7 | 5,400 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 28 Feb 2025 | 825 | 157,775 (0%) | 0% | 5.7 | 4,719 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 742 | 158,992 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 28 Feb 2025 | 392 | 158,600 (0%) | 0% | 5.7 | 2,242 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 04 Jan 2025 | 527 | 158,250 (0%) | 0% | 3.7 | 1,955 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.19 per share. | 07 Dec 2024 | 1,759 | 158,777 (0%) | 0% | 4.2 | 7,370 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.58 per share. | 28 Nov 2024 | 816 | 160,536 (0%) | 0% | 4.6 | 3,737 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.97 per share. | 04 Oct 2024 | 479 | 161,352 (0%) | 0% | 5.0 | 2,381 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.18 per share. | 07 Sep 2024 | 1,759 | 161,831 (0%) | 0% | 5.2 | 9,112 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.76 per share. | 28 Aug 2024 | 817 | 163,590 (0%) | 0% | 5.8 | 4,706 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.38 per share. | 04 Jul 2024 | 479 | 164,407 (0%) | 0% | 8.4 | 4,014 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.27 per share. | 07 Jun 2024 | 1,759 | 164,886 (0%) | 0% | 9.3 | 16,306 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.52 per share. | 28 May 2024 | 817 | 166,645 (0%) | 0% | 9.5 | 7,778 | Common Stock |
| Nevro Corp | Kashif Rashid | SVP, Corp Dev and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.21 per share. | 04 Apr 2024 | 479 | 165,983 (0%) | 0% | 13.2 | 6,328 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 84,326 | 173,507 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.32 per share. | 07 Mar 2024 | 7,045 | 166,462 (0%) | 0% | 15.3 | 107,929 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 743 | 89,606 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 04 Mar 2024 | 425 | 89,181 (0%) | 0% | 14.5 | 6,167 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.22 per share. | 02 Mar 2024 | 1,790 | 88,863 (0%) | 0% | 14.2 | 25,454 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.82 per share. | 28 Feb 2024 | 898 | 90,653 (0%) | 0% | 14.8 | 13,308 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.39 per share. | 04 Jan 2024 | 526 | 91,551 (0%) | 0% | 19.4 | 10,199 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.67 per share. | 28 Nov 2023 | 800 | 92,077 (0%) | 0% | 16.7 | 13,336 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.07 per share. | 04 Oct 2023 | 1,879 | 92,877 (0%) | 0% | 18.1 | 33,954 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.39 per share. | 28 Aug 2023 | 800 | 94,756 (0%) | 0% | 19.4 | 15,512 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.27 per share. | 04 Jun 2023 | 450 | 95,556 (0%) | 0% | 28.3 | 12,722 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.45 per share. | 28 May 2023 | 800 | 96,006 (0%) | 0% | 26.5 | 21,160 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 39,282 | 96,245 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.99 per share. | 02 Mar 2023 | 1,595 | 56,963 (0%) | 0% | 34.0 | 54,214 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.44 per share. | 28 Feb 2023 | 3,359 | 58,558 (0%) | 0% | 31.4 | 105,607 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.30 per share. | 01 Nov 2022 | 2,134 | 61,917 (0%) | 0% | 39.3 | 83,866 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 10,710 | 64,051 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.49 per share. | 04 Jun 2022 | 446 | 53,341 (0%) | 0% | 46.5 | 20,735 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Purchase of securities on an exchange or from another person at price $ 44.50 per share. | 09 May 2022 | 2,250 | 53,526 (0%) | 0% | 44.5 | 100,126 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Purchase of securities on an exchange or from another person at price $ 64.04 per share. | 11 Mar 2022 | 1,500 | 51,276 (0%) | 0% | 64.0 | 96,067 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.27 per share. | 02 Mar 2022 | 1,591 | 49,776 (0%) | 0% | 71.3 | 113,391 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 18,249 | 51,367 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.07 per share. | 02 Jan 2022 | 1,423 | 33,118 (0%) | 0% | 81.1 | 115,363 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Purchase of securities on an exchange or from another person at price $ 101.05 per share. | 11 Nov 2021 | 2,000 | 34,541 (0%) | 0% | 101.1 | 202,100 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.26 per share. | 01 Nov 2021 | 2,137 | 32,541 (0%) | 0% | 116.3 | 248,448 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 148.77 per share. | 04 Jun 2021 | 449 | 34,678 (0%) | 0% | 148.8 | 66,798 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 7,136 | 35,619 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.11 per share. | 02 Mar 2021 | 640 | 34,979 (0%) | 0% | 168.1 | 107,590 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.10 per share. | 02 Jan 2021 | 1,365 | 28,483 (0%) | 0% | 173.1 | 236,282 | Common Stock |
| Nevro Corp | Kashif Rashid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.21 per share. | 01 Nov 2020 | 2,192 | 29,848 (0%) | 0% | 149.2 | 327,068 | Common Stock |